Literature DB >> 8062953

Sperm morphology as diagnosed by strict criteria: probing the impact of teratozoospermia on fertilization rate and pregnancy outcome in a large in vitro fertilization population.

D R Grow1, S Oehninger, H J Seltman, J P Toner, R J Swanson, T F Kruger, S J Muasher.   

Abstract

OBJECTIVE: To investigate the predictive value of sperm morphology assessed by strict criteria on IVF outcome.
DESIGN: Retrospective analysis of all IVF cycles (January 1987 to December 1992). MAIN OUTCOME MEASURES: All patients were assigned to one of three groups based on sperm morphology: P-pattern (< 4% normal forms), G-pattern (4% to 14% normal forms), and N-pattern (> 14% normal forms). Morphology pattern was related to other semen characteristics and IVF outcome.
RESULTS: Despite corrective measures at oocyte insemination, the fertilization rate was significantly different among the three morphology groups, P < G < N. N-pattern sperm produced a mean fertilization rate over 85% regardless of low motility or concentration. In a cohort study, P-pattern cycles produced a lower implantation rate and lower ongoing pregnancy rate, independent of the lower fertilization rate.
CONCLUSIONS: Strict morphology is an excellent biomarker of sperm fertilizing capacity, independent of motility and concentration. P-pattern sperm may denote a poorer prognosis for establishing a pregnancy, even after a satisfactory fertilization rate is achieved.

Entities:  

Mesh:

Year:  1994        PMID: 8062953     DOI: 10.1016/s0015-0282(16)56946-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  23 in total

1.  Assessment of the dominant abnormal form is useful for predicting the outcome of intracytoplasmic sperm injection in the case of severe teratozoospermia.

Authors:  Y Osawa; K Sueoka; S Iwata; M Shinohara; N Kobayashi; N Kuji; Y Yoshimura
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

2.  Intracytoplasmic sperm injection increases embryo fragmentation without affecting clinical outcome.

Authors:  J L Frattarelli; M P Leondires; B T Miller; J H Segars
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

3.  Acrosome index is not an absolute predictor of the outcome following conventional in vitro fertilization and intracytoplasmic sperm injection.

Authors:  B Söderlund; K Lundin
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

4.  An evaluation of the efficacy of in vitro fertilization with intracytoplasmic sperm injection for sperm with low hypoosmotic swelling test scores and poor morphology.

Authors:  Matthew Check; Jerome H Check; Donna Summers-Chase; Kimberly Swenson; Wei Yuan
Journal:  J Assist Reprod Genet       Date:  2003-05       Impact factor: 3.412

Review 5.  Male factor infertility and ART.

Authors:  Herman Tournaye
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

6.  Quality assurance and quality control in the laboratory andrology.

Authors:  Allan A Pacey
Journal:  Asian J Androl       Date:  2010-01       Impact factor: 3.285

Review 7.  Measurement and significance of sperm morphology.

Authors:  Roelof Menkveld; Cas A G Holleboom; Johann P T Rhemrev
Journal:  Asian J Androl       Date:  2010-11-15       Impact factor: 3.285

8.  Fertilization, embryo quality, and cryosurvival in in vitro fertilization and intracytoplasmic sperm injection cycles.

Authors:  J M Moilanen; M Tulppala; I Reima; O Hovatta
Journal:  J Assist Reprod Genet       Date:  1999-01       Impact factor: 3.412

9.  Optimization of IVF pregnancy outcomes with donor spermatozoa.

Authors:  Jeff G Wang; Nataki C Douglas; Robert Prosser; Daniel Kort; Janet M Choi; Mark V Sauer
Journal:  J Assist Reprod Genet       Date:  2009-01-28       Impact factor: 3.412

Review 10.  Role of Abnormal Sperm Morphology in Predicting Pregnancy Outcomes.

Authors:  Samuel A Shabtaie; Sabrina A Gerkowicz; Taylor P Kohn; Ranjith Ramasamy
Journal:  Curr Urol Rep       Date:  2016-09       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.